1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5:75–92.
2. Sand BB, Marner K, Norn MS. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial. Acta Ophthalmol (Copenh). 1989; 67:181–3.
3. Nishida T, Nakamura M, Mishima H, Otori T. Hyaluronan stimulates corneal epithelial migration. Exp Eye Res. 1991; 53:753–8.
Article
4. Camillieri G, Bucolo C, Rossi S, Drago F. Hyaluronan-induced stimulation of corneal wound healing is a pure pharmacological effect. J Ocul Pharmacol Ther. 2004; 20:548–53.
Article
5. Inoue M, Katakami C. The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Vis Sci. 1993; 34:2313–5.
6. Johnson ME, Murphy PJ, Boulton M. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefes Arch Clin Exp Ophthalmol. 2006; 244:109–12.
Article
7. Nakamura M, Hikida M, Nakano T, et al. Characterization of water retentive properties of hyaluronan. Cornea. 1993; 12:433–6.
Article
8. Snibson GR, Greaves JL, Soper ND, et al. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Eye (Lond). 1990; 4(Pt 4):594–602.
Article
9. Avisar R, Creter D, Levinsky H, Savir H. Comparative study of tear substitutes and their immediate effect on the precorneal tear film. Isr J Med Sci. 1997; 33:194–7.
10. Gomes JA, Amankwah R, Powell-Richards A, Dua HS. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol. 2004; 88:821–5.
Article
11. Joseph A, Powell-Richards AO, Shanmuganathan VA, Dua HS. Epithelial cell characteristics of cultured human limbal explants. Br J Ophthalmol. 2004; 88:393–8.
Article
12. Sugiyama T, Miyauchi S, Machida A, et al. The effect of sodium hyaluronate on the migration of rabbit corneal epithelium. II. The effect of topical administration. J Ocul Pharmacol. 1991; 7:53–64.
Article
13. Algawi K, Agrell B, Goggin M, O'Keefe M. Randomized clinical trial of topical sodium hyaluronate after excimer laser photorefractive keratectomy. J Refract Surg. 1995; 11:42–4.
Article
14. Miyauchi S, Sugiyama T, Machida A, et al. The effect of sodium hyaluronate on the migration of rabbit corneal epithelium. I. An in vitro study. J Ocul Pharmacol. 1990; 6:91–9.
Article
15. Asari A, Morita M, Sekiguchi T, et al. Hyaluronan, CD44 and fibronectin in rabbit corneal epithelial wound healing. Jpn J Ophthalmol. 1996; 40:18–25.
16. Brignole F, Pisella PJ, Dupas B, et al. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol. 2005; 243:531–8.
Article
17. Zhu SN, Nölle B, Duncker G. Expression of adhesion molecule CD44 on human corneas. Br J Ophthalmol. 1997; 81:80–4.
Article
18. Adler R. Mechanisms of photoreceptor death in retinal degenerations. From the cell biology of the 1990s to the ophthalmology of the 21st century? Arch Ophthalmol. 1996; 114:79–83.
Article
19. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995; 267:1456–62.
Article
20. Wee WR, Wang XW, McDonnell PJ. Effect of artificial tears on cultured keratocytes in vitro. Cornea. 1995; 14:273–9.
Article